The Zacks Analyst Blog Highlights ADMA Biologics, Tarsus Pharmaceuticals, Stoke Therapeutics, Inc. and ChromaDex

Zacks Dec 26 09:05 ET

4 Drug, Biotech Stocks Rising More Than 50% in 2024 With Room to Grow

Zacks Dec 24 11:00 ET

ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility

ADMA BiologicsDec 20 00:00 ET

4 Biotech Stocks Most Wall Street Analysts Are Bullish About

Zacks Dec 19 12:30 ET

Mizuho Securities Maintains ADMA Biologics(ADMA.US) With Buy Rating, Announces Target Price $28

Moomoo NewsDec 17 12:32 ET · Ratings

Express News | ADMA Biologics Inc : Mizuho Raises Target Price to $28 From $24

ReutersDec 17 06:38 ET